Header Logo

Johanna Seddon

Concepts (693)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
126
2023
166
31.560
Why?
Polymorphism, Single Nucleotide
44
2022
434
7.910
Why?
Genetic Predisposition to Disease
45
2022
596
6.800
Why?
Complement Factor H
25
2020
142
5.150
Why?
Retinal Drusen
15
2022
16
4.900
Why?
Choroidal Neovascularization
13
2020
26
4.570
Why?
Genetic Variation
22
2020
351
3.650
Why?
Geographic Atrophy
9
2018
18
3.480
Why?
Genotype
40
2021
596
2.980
Why?
Risk Factors
102
2023
4604
2.970
Why?
Disease Progression
32
2023
869
2.940
Why?
Proteins
16
2020
734
2.880
Why?
Choroid
7
2020
20
2.740
Why?
Tomography, Optical Coherence
9
2023
175
2.640
Why?
Aged
147
2021
11982
2.520
Why?
Complement Factor I
7
2022
9
2.400
Why?
Wet Macular Degeneration
5
2017
20
2.290
Why?
Visual Acuity
25
2020
90
2.170
Why?
Smoking
22
2020
761
2.150
Why?
Male
164
2021
24927
2.020
Why?
Humans
252
2023
54534
2.010
Why?
Aged, 80 and over
67
2020
4588
2.000
Why?
Phenotype
21
2019
1007
1.970
Why?
Female
167
2021
28392
1.920
Why?
Melanoma
53
2021
327
1.800
Why?
Retinoblastoma
18
2021
27
1.800
Why?
Case-Control Studies
39
2021
991
1.740
Why?
Complement C3
10
2020
60
1.730
Why?
Uveal Neoplasms
41
1993
51
1.700
Why?
Middle Aged
141
2021
14579
1.690
Why?
Aging
17
2020
709
1.690
Why?
Follow-Up Studies
49
2022
2035
1.650
Why?
High-Temperature Requirement A Serine Peptidase 1
8
2020
9
1.640
Why?
Cataract
26
2016
50
1.630
Why?
Lipase
5
2011
41
1.580
Why?
Complement System Proteins
6
2021
127
1.520
Why?
Dog Diseases
3
2021
53
1.490
Why?
Genome-Wide Association Study
10
2016
303
1.470
Why?
Retina
6
2023
107
1.450
Why?
Diet
13
2017
648
1.430
Why?
Prospective Studies
44
2023
2807
1.400
Why?
Serine Endopeptidases
5
2016
77
1.360
Why?
Dogs
5
2021
299
1.340
Why?
Retinal Vessels
4
2016
16
1.290
Why?
Twins, Monozygotic
5
2014
63
1.290
Why?
Pedigree
14
2016
169
1.280
Why?
Vitamins
8
2017
85
1.280
Why?
Risk Assessment
11
2019
1707
1.250
Why?
Diet, Mediterranean
2
2020
33
1.250
Why?
Body Mass Index
11
2020
915
1.220
Why?
Antioxidants
10
2016
210
1.220
Why?
Fluorescein Angiography
12
2017
40
1.190
Why?
Retinal Neoplasms
12
2021
16
1.150
Why?
Vascular Endothelial Growth Factor A
4
2020
179
1.140
Why?
Gene-Environment Interaction
2
2017
48
1.060
Why?
Incidence
30
2021
1151
1.060
Why?
C-Reactive Protein
4
2010
173
1.050
Why?
Vitamin D
3
2017
151
1.020
Why?
Life Style
5
2023
326
1.000
Why?
Mutation, Missense
4
2016
171
1.000
Why?
Environment
5
2015
122
0.970
Why?
Macula Lutea
9
2015
20
0.960
Why?
Diseases in Twins
4
2011
48
0.950
Why?
Alleles
11
2020
418
0.940
Why?
Retinal Pigment Epithelium
3
2016
26
0.930
Why?
Cholesterol, HDL
4
2012
82
0.910
Why?
Fatty Acids, Omega-3
5
2013
44
0.900
Why?
Dietary Fats
4
2013
205
0.850
Why?
Neoplasms, Second Primary
9
2021
37
0.830
Why?
Genetic Testing
2
2015
110
0.830
Why?
Cohort Studies
23
2021
2266
0.790
Why?
Quantitative Trait Loci
1
2021
68
0.780
Why?
Deafness
1
2021
32
0.770
Why?
Choroid Neoplasms
17
2005
21
0.750
Why?
Prevalence
15
2019
1164
0.740
Why?
Ciliary Arteries
1
2020
1
0.730
Why?
Models, Genetic
6
2021
253
0.730
Why?
United States
42
2021
6965
0.730
Why?
Genetic Association Studies
4
2021
112
0.720
Why?
Eye Diseases, Hereditary
2
2016
3
0.720
Why?
Vision Disorders
4
2018
41
0.700
Why?
Complement C2
7
2016
9
0.700
Why?
Biomarkers
5
2017
1065
0.690
Why?
Apolipoproteins E
5
2012
94
0.690
Why?
Survivors
11
2019
146
0.690
Why?
Gene Frequency
10
2015
127
0.690
Why?
Longitudinal Studies
9
2023
1155
0.680
Why?
Eye Proteins
5
2018
68
0.680
Why?
Complement C9
2
2021
4
0.670
Why?
Haplotypes
7
2011
116
0.670
Why?
Blindness
3
2015
35
0.660
Why?
Angiogenesis Inhibitors
2
2017
69
0.660
Why?
ATP-Binding Cassette Transporters
3
2011
37
0.640
Why?
Prognosis
19
2021
1357
0.640
Why?
Chromosome Mapping
6
2016
290
0.630
Why?
Collagen Type VIII
2
2016
2
0.620
Why?
Complement Factor B
6
2016
11
0.620
Why?
Ophthalmology
1
2017
16
0.610
Why?
Zinc
6
2008
87
0.610
Why?
Awards and Prizes
1
2017
28
0.610
Why?
Algorithms
6
2023
941
0.610
Why?
Macrophages
2
2020
964
0.600
Why?
Eye Diseases
4
2013
33
0.600
Why?
Vitamin D Deficiency
1
2017
49
0.590
Why?
Cataract Extraction
15
2009
34
0.590
Why?
Bruch Membrane
1
2016
4
0.580
Why?
Chymotrypsin
1
2016
28
0.570
Why?
Epigenomics
2
2014
53
0.570
Why?
Fibrinogen
2
2022
35
0.570
Why?
Zinc Compounds
1
2016
7
0.570
Why?
Heterozygote
7
2022
158
0.560
Why?
Vitamin B Complex
1
2016
22
0.550
Why?
Homocysteine
2
2006
54
0.540
Why?
Aspirin
5
2013
178
0.540
Why?
Folic Acid
1
2016
57
0.540
Why?
Adult
79
2021
14274
0.530
Why?
Fish Products
2
2006
6
0.520
Why?
Cancer Survivors
3
2021
71
0.520
Why?
Inflammation
2
2020
1049
0.520
Why?
Lod Score
4
2014
28
0.520
Why?
Severity of Illness Index
6
2020
1273
0.510
Why?
Ubiquitin-Protein Ligases
1
2016
197
0.510
Why?
Proportional Hazards Models
12
2013
637
0.490
Why?
Risk
15
2014
361
0.480
Why?
Exome
1
2014
69
0.480
Why?
Hearing Loss, Sensorineural
1
2014
46
0.470
Why?
Multivariate Analysis
12
2014
878
0.470
Why?
Polymorphism, Genetic
4
2009
189
0.470
Why?
Diet Records
7
2017
54
0.470
Why?
Dietary Supplements
8
2017
230
0.470
Why?
Women's Health
4
2016
410
0.470
Why?
Odds Ratio
10
2015
791
0.460
Why?
Environmental Exposure
2
2013
201
0.460
Why?
Amino Acid Substitution
4
2016
250
0.450
Why?
Optic Atrophy
1
2013
3
0.450
Why?
Genetic Linkage
4
2009
99
0.450
Why?
Lutein
5
2010
23
0.450
Why?
Complement Pathway, Alternative
2
2011
27
0.450
Why?
Myopia
1
2012
3
0.430
Why?
Complement C1
1
2012
5
0.430
Why?
Twins, Dizygotic
3
2011
54
0.420
Why?
Markov Chains
1
2012
29
0.420
Why?
Age of Onset
4
2020
161
0.420
Why?
Fundus Oculi
9
2016
14
0.420
Why?
Models, Biological
4
2018
1125
0.420
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
187
0.410
Why?
Glaucoma, Open-Angle
2
2011
21
0.410
Why?
Protons
19
1993
58
0.410
Why?
Photography
9
2020
37
0.410
Why?
Minerals
2
2007
21
0.410
Why?
Penetrance
1
2011
9
0.410
Why?
Models, Theoretical
2
2013
250
0.410
Why?
Tissue Inhibitor of Metalloproteinase-3
4
2020
5
0.410
Why?
Demography
3
2023
177
0.410
Why?
DNA
1
2016
760
0.410
Why?
Neoplasms, Radiation-Induced
5
2019
25
0.410
Why?
Optic Disk Drusen
1
2011
1
0.400
Why?
Collagen Type X
1
2011
4
0.400
Why?
Betaine
1
2011
9
0.400
Why?
Retrospective Studies
17
2016
5288
0.390
Why?
Methionine
1
2011
57
0.390
Why?
Albuminuria
1
2011
20
0.390
Why?
Rhipicephalus
1
2010
1
0.380
Why?
Acaricides
1
2010
1
0.380
Why?
Pyrethrins
1
2010
3
0.380
Why?
Protein-Tyrosine Kinases
1
2011
116
0.380
Why?
Sodium Channels
1
2010
20
0.370
Why?
Survival Analysis
5
2016
505
0.370
Why?
Drug Resistance
1
2010
88
0.360
Why?
Surveys and Questionnaires
18
2011
2428
0.350
Why?
Kidney Diseases
1
2011
148
0.350
Why?
Neoplasm Proteins
1
2011
263
0.350
Why?
Skin Neoplasms
6
2021
399
0.340
Why?
Toll-Like Receptor 3
1
2009
67
0.340
Why?
Time Factors
15
2016
3322
0.340
Why?
Biological Evolution
1
2009
107
0.340
Why?
Animals
17
2021
18861
0.330
Why?
Histocompatibility Antigens Class II
1
2009
176
0.330
Why?
Breeding
2
2021
26
0.330
Why?
Australia
2
2021
74
0.320
Why?
Sequence Analysis, DNA
4
2013
380
0.320
Why?
Point Mutation
3
2010
163
0.320
Why?
Mutation
6
2021
2310
0.310
Why?
DNA Methylation
3
2014
263
0.310
Why?
Eye Neoplasms
8
2014
15
0.310
Why?
Complement C3b
2
2020
20
0.310
Why?
Immunohistochemistry
3
2020
816
0.310
Why?
Health Behavior
1
2011
471
0.310
Why?
Reproducibility of Results
10
2016
1428
0.300
Why?
DNA-Binding Proteins
1
2014
1122
0.300
Why?
Siblings
4
2012
46
0.300
Why?
Cross-Sectional Studies
7
2016
2318
0.300
Why?
Estrogen Replacement Therapy
3
2007
97
0.300
Why?
Sarcoma
4
2019
52
0.300
Why?
Carotenoids
8
2007
59
0.290
Why?
Polycystic Kidney Diseases
1
2006
14
0.290
Why?
Ranibizumab
2
2017
14
0.290
Why?
TRPP Cation Channels
1
2006
21
0.290
Why?
Nutritional Physiological Phenomena
3
2017
29
0.280
Why?
Intravitreal Injections
2
2017
39
0.280
Why?
Models, Statistical
5
2012
299
0.280
Why?
Radiotherapy
6
2019
55
0.280
Why?
Linkage Disequilibrium
3
2011
47
0.270
Why?
Diagnostic Techniques, Ophthalmological
1
2006
13
0.270
Why?
Energy Intake
6
2017
232
0.270
Why?
Polymerase Chain Reaction
3
2019
480
0.270
Why?
Hypertension
2
2011
578
0.270
Why?
Sensitivity and Specificity
4
2013
1027
0.260
Why?
Feeding Behavior
7
2008
322
0.260
Why?
Genome, Human
2
2005
213
0.260
Why?
Wolves
1
2004
3
0.260
Why?
Diabetes Mellitus
2
2009
539
0.250
Why?
Genetic Drift
1
2004
15
0.250
Why?
Genes, MHC Class II
1
2004
33
0.250
Why?
Chromosomes, Human
1
2005
52
0.250
Why?
Genetics, Population
1
2004
39
0.250
Why?
Activities of Daily Living
6
2000
289
0.250
Why?
Alcohol Drinking
6
2000
291
0.250
Why?
Diabetes Mellitus, Type 2
1
2011
663
0.240
Why?
Gene Expression Regulation
2
2014
1516
0.240
Why?
Nuts
1
2003
7
0.240
Why?
Registries
6
2011
742
0.230
Why?
Interleukin-6
1
2005
295
0.230
Why?
United Kingdom
2
2021
55
0.230
Why?
Body Constitution
1
2003
16
0.230
Why?
Adolescent
30
2021
5560
0.230
Why?
Glaucoma
5
2016
25
0.230
Why?
Ciliary Body
7
2000
10
0.220
Why?
Contraceptives, Oral, Hormonal
1
2002
19
0.220
Why?
Reproductive History
1
2002
20
0.220
Why?
Area Under Curve
2
2013
119
0.220
Why?
Cardiovascular Diseases
6
2007
737
0.220
Why?
Dietary Fats, Unsaturated
3
2008
23
0.220
Why?
Fovea Centralis
3
1996
14
0.210
Why?
Diagnostic Self Evaluation
1
2022
20
0.210
Why?
Lipids
3
2010
292
0.210
Why?
Logistic Models
6
2014
1235
0.210
Why?
Postmenopause
2
2006
296
0.210
Why?
Vitamin A
5
2007
26
0.200
Why?
Machine Learning
1
2023
119
0.200
Why?
Microscopy, Confocal
2
2020
218
0.200
Why?
Radiation Injuries
7
2009
50
0.200
Why?
Tissue Donors
2
2020
148
0.200
Why?
Ultraviolet Rays
3
2000
120
0.200
Why?
High-Throughput Nucleotide Sequencing
2
2014
244
0.200
Why?
Double-Blind Method
6
2016
603
0.200
Why?
Infant
12
2019
1464
0.200
Why?
Rehabilitation
1
2000
5
0.190
Why?
Health Risk Behaviors
1
2020
7
0.190
Why?
Vision, Low
1
2000
10
0.190
Why?
Genetic Markers
3
2012
115
0.190
Why?
HSP110 Heat-Shock Proteins
1
2020
1
0.190
Why?
Hormone Replacement Therapy
1
2000
37
0.190
Why?
Plant Lectins
1
2020
7
0.180
Why?
Survival Rate
9
2021
715
0.180
Why?
Age Factors
15
2019
1474
0.180
Why?
Molecular Epidemiology
2
2010
23
0.180
Why?
Staining and Labeling
3
2020
120
0.180
Why?
Geriatric Assessment
3
2015
162
0.170
Why?
Intraocular Pressure
3
2005
27
0.170
Why?
Child, Preschool
11
2019
1772
0.170
Why?
Obesity
3
2007
1183
0.170
Why?
Bone Neoplasms
2
2019
112
0.170
Why?
Retinal Diseases
4
1994
22
0.170
Why?
Endothelium, Vascular
1
2020
155
0.170
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2008
75
0.160
Why?
Health Surveys
1
1999
297
0.160
Why?
Public Health
2
2003
163
0.160
Why?
Ascorbic Acid
5
2007
52
0.160
Why?
Vitamin E
5
2007
51
0.150
Why?
DNA Mutational Analysis
3
2003
179
0.150
Why?
Pigment Epithelium of Eye
6
2009
12
0.150
Why?
Young Adult
7
2021
3895
0.150
Why?
Predictive Value of Tests
5
2013
882
0.150
Why?
Collagen Type IV
1
2016
2
0.150
Why?
Sequence Alignment
2
2010
288
0.150
Why?
Nurses
3
2016
96
0.150
Why?
Base Sequence
2
2013
1310
0.150
Why?
Riboflavin
2
2016
13
0.150
Why?
Quality of Life
3
2008
891
0.150
Why?
False Positive Reactions
2
2013
72
0.140
Why?
Mastocytosis, Systemic
1
2016
6
0.140
Why?
Choroid Diseases
1
2016
5
0.140
Why?
Cell Degranulation
1
2016
21
0.140
Why?
Regional Blood Flow
1
2016
92
0.140
Why?
Thiamine
1
2016
19
0.140
Why?
Microsatellite Repeats
2
2006
37
0.140
Why?
Mast Cells
1
2016
45
0.140
Why?
Autoantigens
1
2016
127
0.130
Why?
Retinal Degeneration
1
2016
27
0.130
Why?
Bevacizumab
1
2015
48
0.130
Why?
Regression Analysis
11
2010
474
0.130
Why?
Equipment Design
1
2016
291
0.130
Why?
Retinoblastoma Protein
2
2012
35
0.130
Why?
Nuclear Proteins
1
2020
758
0.130
Why?
Germ-Line Mutation
2
2012
47
0.130
Why?
Neovascularization, Pathologic
1
1996
124
0.130
Why?
Immunity, Innate
1
2020
737
0.130
Why?
Neuroglia
1
2015
72
0.130
Why?
Evoked Potentials, Auditory, Brain Stem
1
2014
8
0.130
Why?
Population Surveillance
3
2019
209
0.130
Why?
Computer Simulation
2
2009
443
0.130
Why?
Cholesterol, LDL
2
2010
114
0.120
Why?
Gliosis
1
2014
22
0.120
Why?
Retinal Vein
2
1998
4
0.120
Why?
Bestrophins
3
2003
3
0.120
Why?
Disease
1
2014
26
0.120
Why?
Eye Enucleation
7
1993
11
0.120
Why?
Magnetic Resonance Spectroscopy
3
1990
263
0.120
Why?
DNA Copy Number Variations
1
2014
63
0.120
Why?
Leiomyosarcoma
2
2011
10
0.120
Why?
Optic Disk
3
1993
8
0.120
Why?
Brachytherapy
3
2009
40
0.120
Why?
Molecular Sequence Data
2
2010
1969
0.120
Why?
Chloride Channels
3
2003
27
0.120
Why?
Diagnostic Tests, Routine
1
1994
37
0.120
Why?
Child
13
2019
4086
0.120
Why?
Triglycerides
2
2010
237
0.120
Why?
Genotyping Techniques
1
2013
12
0.110
Why?
Eating
3
2007
138
0.110
Why?
Retinal Artery
1
1993
1
0.110
Why?
Complement Activation
1
2013
53
0.110
Why?
Patient Compliance
1
2015
352
0.110
Why?
Oligonucleotide Array Sequence Analysis
2
2014
284
0.110
Why?
Discriminant Analysis
1
2012
16
0.110
Why?
Electrooculography
2
2003
6
0.110
Why?
Nuclear Family
2
2003
18
0.110
Why?
Treatment Outcome
3
2015
4381
0.110
Why?
Cobalt Radioisotopes
4
2009
5
0.110
Why?
Nutrition Surveys
2
2011
155
0.110
Why?
Genetic Loci
1
2013
104
0.110
Why?
Massachusetts
7
2002
2071
0.110
Why?
Eye Color
2
2000
3
0.110
Why?
Kinetics
1
2014
724
0.110
Why?
Skin
2
1992
341
0.100
Why?
Principal Component Analysis
1
2011
58
0.100
Why?
ATP Binding Cassette Transporter 1
1
2011
10
0.100
Why?
Uterine Neoplasms
1
2011
29
0.100
Why?
Behavior
1
2011
37
0.100
Why?
Protein Conformation
1
2014
745
0.100
Why?
Anthropometry
1
2011
80
0.100
Why?
Observer Variation
3
2006
186
0.100
Why?
Mass Screening
3
2008
583
0.100
Why?
Iris
1
1990
3
0.090
Why?
Medical Errors
1
2012
180
0.090
Why?
Medical Records Systems, Computerized
1
1991
66
0.090
Why?
Classification
1
1990
11
0.090
Why?
Complement C3b Inactivator Proteins
1
2010
4
0.090
Why?
Family
2
2009
202
0.090
Why?
Boston
2
2011
316
0.090
Why?
Radiotherapy Dosage
5
2000
67
0.090
Why?
Introns
2
2008
103
0.090
Why?
Blood Proteins
1
2010
66
0.090
Why?
Lipoproteins, HDL
1
2010
36
0.090
Why?
Liver Neoplasms
6
1992
267
0.090
Why?
Models, Molecular
1
2014
1099
0.090
Why?
Macular Edema
1
2010
19
0.090
Why?
Scavenger Receptors, Class B
1
2009
3
0.090
Why?
Drug Therapy, Combination
2
2008
398
0.090
Why?
Exons
2
2008
190
0.090
Why?
Lens, Crystalline
1
2009
15
0.090
Why?
Cattle
1
2010
307
0.090
Why?
HLA Antigens
1
2009
58
0.090
Why?
Protein Binding
1
2014
1539
0.090
Why?
Major Histocompatibility Complex
1
2009
83
0.090
Why?
Leukocytes
1
2009
104
0.090
Why?
Membrane Proteins
2
2007
813
0.090
Why?
Sclera
1
1989
8
0.080
Why?
Pregnancy Complications, Neoplastic
2
1993
10
0.080
Why?
Gene Deletion
1
2010
293
0.080
Why?
Seafood
1
2008
12
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
520
0.080
Why?
Chromosomes, Human, Pair 4
1
2008
16
0.080
Why?
Eyeglasses
1
2008
9
0.080
Why?
Pharmacogenetics
1
2008
21
0.080
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
448
0.080
Why?
ROC Curve
1
2008
246
0.080
Why?
Sex Distribution
2
2009
258
0.080
Why?
Eyelid Neoplasms
3
1986
9
0.070
Why?
Epidemiologic Methods
2
1999
66
0.070
Why?
Amino Acid Sequence
1
2010
1567
0.070
Why?
Evaluation Studies as Topic
6
1992
104
0.070
Why?
Laser Therapy
2
1997
34
0.070
Why?
Estrogens, Conjugated (USP)
1
2006
29
0.070
Why?
Cell Count
2
2016
126
0.070
Why?
Ultrasonics
1
1986
15
0.070
Why?
Histocompatibility Antigens Class I
1
2007
122
0.070
Why?
Calcium Channels
1
2006
107
0.070
Why?
Cryptorchidism
1
1985
10
0.070
Why?
Infant, Newborn
3
2019
1255
0.070
Why?
Chromosomes, Human, Pair 20
1
2005
7
0.070
Why?
Chromosomes, Human, Pair 2
1
2005
9
0.070
Why?
Chi-Square Distribution
1
2006
395
0.070
Why?
Lipoprotein(a)
1
2005
8
0.070
Why?
Chromosomes, Human, Pair 6
1
2005
16
0.070
Why?
Chromosomes, Human, Pair 19
1
2005
15
0.070
Why?
Vascular Cell Adhesion Molecule-1
1
2005
14
0.070
Why?
Chromosomes, Human, Pair 1
1
2005
21
0.070
Why?
Progesterone
1
2006
161
0.070
Why?
Eye Injuries
3
1991
11
0.070
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2005
28
0.070
Why?
Intercellular Adhesion Molecule-1
1
2005
50
0.070
Why?
Recombination, Genetic
1
2006
222
0.070
Why?
Intracellular Signaling Peptides and Proteins
1
2007
312
0.060
Why?
Breast Neoplasms
1
2014
1106
0.060
Why?
Skull Neoplasms
1
1985
6
0.060
Why?
Scandinavian and Nordic Countries
1
2004
4
0.060
Why?
Neoplasms, Multiple Primary
3
2014
28
0.060
Why?
Founder Effect
1
2004
9
0.060
Why?
Population Dynamics
1
2004
17
0.060
Why?
Cause of Death
2
2019
176
0.060
Why?
Physicians
4
1994
424
0.060
Why?
Glycemic Index
1
2004
33
0.060
Why?
Evidence-Based Medicine
1
2007
419
0.060
Why?
Species Specificity
1
2004
325
0.060
Why?
Dietary Carbohydrates
1
2004
80
0.060
Why?
Vegetables
1
2004
86
0.060
Why?
Cricetinae
4
2021
382
0.060
Why?
Diagnosis-Related Groups
1
2004
86
0.060
Why?
Fruit
1
2004
106
0.060
Why?
Light Coagulation
3
1996
5
0.060
Why?
Hyperglycemia
1
2004
103
0.060
Why?
Diet Surveys
4
2008
82
0.060
Why?
Age Distribution
1
2004
260
0.060
Why?
Statistics, Nonparametric
1
2003
194
0.060
Why?
Neoplasms, Hormone-Dependent
1
1982
7
0.060
Why?
National Institutes of Health (U.S.)
1
2003
92
0.060
Why?
Data Collection
3
1994
384
0.050
Why?
Conjunctival Neoplasms
1
1982
1
0.050
Why?
Plasmacytoma
1
1982
7
0.050
Why?
Ophthalmologic Surgical Procedures
3
1988
6
0.050
Why?
Retinal Detachment
4
1990
16
0.050
Why?
Receptors, Estrogen
1
1982
126
0.050
Why?
Dose-Response Relationship, Radiation
3
2014
48
0.050
Why?
Brain Neoplasms
1
1985
248
0.050
Why?
Contact Lenses, Extended-Wear
3
1991
3
0.050
Why?
Neoplasm Recurrence, Local
4
1992
298
0.050
Why?
Contact Lenses, Hydrophilic
3
1991
6
0.050
Why?
Fatty Acids, Monounsaturated
1
2001
18
0.050
Why?
Linoleic Acid
1
2001
17
0.050
Why?
Complement Membrane Attack Complex
1
2021
5
0.050
Why?
Fatty Acids, Unsaturated
1
2001
34
0.050
Why?
Guinea Pigs
1
2021
102
0.050
Why?
Polymerization
1
2021
31
0.050
Why?
Hemolysis
1
2021
39
0.050
Why?
alpha-Linolenic Acid
1
2001
4
0.050
Why?
beta Carotene
5
2003
61
0.050
Why?
Cricetulus
1
2021
101
0.050
Why?
Sheep
1
2021
156
0.050
Why?
CHO Cells
1
2021
191
0.050
Why?
Occupational Therapy
1
2000
12
0.050
Why?
Optometry
1
2000
8
0.050
Why?
Diabetes Complications
4
2007
102
0.050
Why?
Health Status
3
1999
413
0.050
Why?
Adipose Tissue
1
2003
294
0.050
Why?
Macrophages, Peritoneal
1
2000
72
0.050
Why?
Hydrocortisone
1
1981
192
0.040
Why?
Twin Studies as Topic
1
1999
15
0.040
Why?
Keratitis
2
1989
9
0.040
Why?
Eye
3
1989
49
0.040
Why?
Health Personnel
2
2001
343
0.040
Why?
New England
5
1991
259
0.040
Why?
Radiotherapy, High-Energy
3
1989
8
0.040
Why?
Retinal Perforations
1
1999
7
0.040
Why?
Zeaxanthins
3
2007
16
0.040
Why?
Xanthophylls
3
2007
19
0.040
Why?
History, 21st Century
1
2019
144
0.040
Why?
History, 20th Century
1
2019
213
0.040
Why?
Terminology as Topic
1
1999
124
0.040
Why?
Sex Factors
5
2011
892
0.040
Why?
Neoplasm Metastasis
3
1991
194
0.040
Why?
Retinal Vein Occlusion
1
1998
11
0.040
Why?
Lung Neoplasms
3
2000
513
0.040
Why?
Genetic Heterogeneity
1
1997
20
0.040
Why?
Health Services Research
1
1999
273
0.040
Why?
Research
1
1999
192
0.040
Why?
Ethanol
1
2000
282
0.040
Why?
Corneal Ulcer
3
1991
3
0.040
Why?
Smoking Cessation
1
2002
515
0.040
Why?
Epidemiologic Studies
1
2016
40
0.040
Why?
Vision Screening
2
1993
8
0.030
Why?
Photoreceptor Cells, Vertebrate
1
2016
10
0.030
Why?
Epithelium
2
1987
96
0.030
Why?
Codon, Nonsense
1
2015
50
0.030
Why?
Docosahexaenoic Acids
2
2008
29
0.030
Why?
Radiation Dosage
2
2009
113
0.030
Why?
Statistics as Topic
3
1997
147
0.030
Why?
Triethylenemelamine
1
2014
1
0.030
Why?
Astrocytes
1
2015
104
0.030
Why?
Antineoplastic Agents, Alkylating
1
2014
26
0.030
Why?
Genes, Retinoblastoma
1
2014
3
0.030
Why?
Self Disclosure
1
1994
38
0.030
Why?
Breast Neoplasms, Male
1
2014
15
0.030
Why?
Sample Size
1
2014
55
0.030
Why?
Single-Blind Method
1
2014
121
0.030
Why?
Cyclotrons
1
1993
3
0.030
Why?
Fatty Acids
2
2001
179
0.030
Why?
Attitude to Health
1
1996
279
0.030
Why?
Contraceptives, Oral
1
1993
27
0.030
Why?
Mental Status Schedule
1
1993
18
0.030
Why?
Biopsy
2
1992
343
0.030
Why?
Random Allocation
2
1991
189
0.030
Why?
Multicenter Studies as Topic
2
1990
97
0.030
Why?
Fibrosis
1
1993
109
0.030
Why?
Uveitis
1
1993
29
0.030
Why?
Accidental Falls
2
1993
142
0.030
Why?
Data Interpretation, Statistical
2
1991
190
0.030
Why?
Meta-Analysis as Topic
1
2013
78
0.030
Why?
Postal Service
1
1992
6
0.030
Why?
Maryland
1
2012
30
0.030
Why?
Complement Factor D
1
2011
4
0.030
Why?
Hand
1
1992
59
0.030
Why?
Actuarial Analysis
3
1988
14
0.030
Why?
Cell Nucleolus
3
1987
68
0.030
Why?
Gene Dosage
1
2011
58
0.030
Why?
Genomics
1
2014
292
0.030
Why?
Exudates and Transudates
2
1988
11
0.020
Why?
Cognition Disorders
1
1993
215
0.020
Why?
Aphakia, Postcataract
1
1991
1
0.020
Why?
Contact Lenses
1
1991
1
0.020
Why?
Forms and Records Control
1
1991
14
0.020
Why?
Placebos
1
1991
72
0.020
Why?
Quality Control
1
1991
63
0.020
Why?
Postoperative Care
2
2008
100
0.020
Why?
Altitude
1
1990
13
0.020
Why?
Sunlight
1
1990
29
0.020
Why?
Personality
1
1990
27
0.020
Why?
Longevity
1
2011
103
0.020
Why?
Particle Accelerators
2
1989
5
0.020
Why?
Radon
1
2009
2
0.020
Why?
Radiation, Ionizing
1
2009
16
0.020
Why?
Elastic Tissue
1
1989
4
0.020
Why?
Diabetic Retinopathy
1
2010
38
0.020
Why?
Magnetic Resonance Imaging
2
2008
1663
0.020
Why?
Occupational Exposure
1
1992
294
0.020
Why?
Delivery of Health Care
1
1994
407
0.020
Why?
Poisson Distribution
1
2009
53
0.020
Why?
Compliance
1
1989
3
0.020
Why?
Carcinoma, Squamous Cell
3
1989
225
0.020
Why?
Analysis of Variance
1
1990
564
0.020
Why?
Dose-Response Relationship, Drug
1
1991
782
0.020
Why?
Socioeconomic Factors
1
1991
779
0.020
Why?
Eicosapentaenoic Acid
1
2008
15
0.020
Why?
Linear Models
2
2004
423
0.020
Why?
Atrophy
1
2008
51
0.020
Why?
Interviews as Topic
1
1990
436
0.020
Why?
Phosphorus
1
1988
17
0.020
Why?
Phosphatidylcholines
1
1988
35
0.020
Why?
Lipid Bilayers
1
1988
48
0.020
Why?
Randomized Controlled Trials as Topic
2
2006
593
0.020
Why?
Health Status Indicators
1
2008
91
0.020
Why?
Developing Countries
1
2008
76
0.020
Why?
Lipid Metabolism
1
2009
191
0.020
Why?
Carcinoma, Basal Cell
2
1989
62
0.020
Why?
Liposomes
1
1988
95
0.020
Why?
Adenomatous Polyposis Coli
1
1987
8
0.020
Why?
Image Interpretation, Computer-Assisted
1
2008
149
0.020
Why?
Radiotherapy, Adjuvant
1
2007
63
0.020
Why?
Calcium Channel Blockers
1
2007
49
0.020
Why?
SEER Program
1
2007
72
0.020
Why?
Chemotherapy, Adjuvant
1
2007
89
0.020
Why?
Visual Fields
2
2000
22
0.020
Why?
Helium
1
1986
7
0.020
Why?
Electrocoagulation
1
1986
11
0.020
Why?
Image Processing, Computer-Assisted
1
1989
576
0.020
Why?
Cryosurgery
1
1986
14
0.020
Why?
Hyperthermia, Induced
1
1985
14
0.020
Why?
Estrogens
1
2006
121
0.020
Why?
Urology
1
1985
20
0.020
Why?
Nasal Cavity
1
2005
7
0.020
Why?
Cytological Techniques
1
1985
23
0.020
Why?
Carcinoma, Hepatocellular
1
1987
161
0.020
Why?
Spinal Cord Neoplasms
1
1985
5
0.020
Why?
Energy Transfer
1
1985
9
0.020
Why?
Chondrosarcoma
1
1985
7
0.020
Why?
Nose Neoplasms
1
2005
14
0.020
Why?
Chordoma
1
1985
6
0.020
Why?
Liver Diseases
1
1985
125
0.010
Why?
Glioma
1
1985
95
0.010
Why?
Neoplasms
2
1992
1131
0.010
Why?
Family Practice
1
1985
195
0.010
Why?
Hepatectomy
1
1984
53
0.010
Why?
Irritants
1
1983
5
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2007
357
0.010
Why?
Confidence Intervals
2
1994
258
0.010
Why?
Risk Reduction Behavior
1
2003
128
0.010
Why?
Pediatrics
1
1985
251
0.010
Why?
Factor Analysis, Statistical
2
1993
97
0.010
Why?
Orbital Neoplasms
1
1982
7
0.010
Why?
Polymorphism, Restriction Fragment Length
1
2001
26
0.010
Why?
Palliative Care
1
1984
178
0.010
Why?
Tomography, X-Ray Computed
1
2008
1246
0.010
Why?
Pregnancy
2
1993
2294
0.010
Why?
DNA Primers
1
2001
295
0.010
Why?
Fishes
1
2001
23
0.010
Why?
Carcinoma, Small Cell
1
2000
18
0.010
Why?
Clinical Trials as Topic
1
2003
392
0.010
Why?
Microsomes
1
2000
11
0.010
Why?
Cell Fractionation
1
2000
31
0.010
Why?
Tobacco Use Disorder
1
1983
235
0.010
Why?
Golgi Apparatus
1
2000
60
0.010
Why?
N-Acetylneuraminic Acid
1
2000
47
0.010
Why?
Glycosylation
1
2000
131
0.010
Why?
Rats, Wistar
1
2000
178
0.010
Why?
Brassica
1
1999
7
0.010
Why?
Spinacia oleracea
1
1999
8
0.010
Why?
Light
1
2000
203
0.010
Why?
Carcinoma, Non-Small-Cell Lung
1
2000
129
0.010
Why?
Remission, Spontaneous
1
1999
11
0.010
Why?
Stress, Psychological
1
1983
418
0.010
Why?
Blood Pressure
1
1981
501
0.010
Why?
Ion Channels
1
1999
86
0.010
Why?
Internship and Residency
1
1985
656
0.010
Why?
Frameshift Mutation
1
1997
24
0.010
Why?
Sequence Deletion
1
1997
115
0.010
Why?
Rats
1
2000
1872
0.010
Why?
Postoperative Complications
2
1992
1009
0.010
Why?
Mesocricetus
2
1985
92
0.010
Why?
Cells, Cultured
1
2000
2090
0.010
Why?
Vision, Ocular
1
1995
24
0.010
Why?
Lenses, Intraocular
1
1994
4
0.010
Why?
Outpatient Clinics, Hospital
1
1993
40
0.010
Why?
Distance Perception
1
1992
1
0.010
Why?
Occupations
1
1993
55
0.010
Why?
Hyperplasia
1
1992
80
0.010
Why?
Platelet Aggregation Inhibitors
1
1994
220
0.010
Why?
Telephone
1
1992
117
0.010
Why?
Necrosis
1
1992
124
0.010
Why?
Automobile Driving
1
1992
55
0.010
Why?
Educational Status
1
1993
274
0.010
Why?
Ophthalmic Solutions
1
1991
11
0.010
Why?
Craniocerebral Trauma
1
1991
56
0.010
Why?
Selection Bias
1
1990
27
0.010
Why?
Wounds, Nonpenetrating
1
1991
81
0.010
Why?
Psychometrics
1
1992
339
0.010
Why?
Hypnotics and Sedatives
1
1991
60
0.010
Why?
Mitosis
1
1992
205
0.010
Why?
Accidents, Traffic
1
1991
143
0.010
Why?
Cardiovascular Agents
1
1991
85
0.010
Why?
Depressive Disorder
1
1993
287
0.010
Why?
Alcoholism
1
1993
286
0.010
Why?
Carcinoma, Merkel Cell
1
1989
8
0.010
Why?
Glaucoma, Neovascular
1
1989
2
0.010
Why?
Chronic Disease
1
1993
704
0.010
Why?
Hygiene
1
1989
11
0.010
Why?
Comorbidity
1
1993
1040
0.010
Why?
Remission Induction
1
1989
134
0.010
Why?
Histological Techniques
1
1988
18
0.010
Why?
Palmitic Acids
1
1988
3
0.010
Why?
Myristic Acids
1
1988
5
0.010
Why?
Myristic Acid
1
1988
9
0.010
Why?
Stearic Acids
1
1988
7
0.010
Why?
Palmitic Acid
1
1988
13
0.010
Why?
Spectrophotometry
1
1988
29
0.010
Why?
Electrochemistry
1
1988
27
0.010
Why?
Hyphema
1
1988
4
0.000
Why?
Eye Foreign Bodies
1
1988
8
0.000
Why?
Chemical Phenomena
1
1988
91
0.000
Why?
Osmolar Concentration
1
1988
88
0.000
Why?
Probability
1
1988
167
0.000
Why?
Colloids
1
1988
46
0.000
Why?
Chemistry
1
1988
32
0.000
Why?
Pigmentation
1
1988
23
0.000
Why?
Retinal Hemorrhage
1
1987
4
0.000
Why?
Sodium
1
1987
57
0.000
Why?
Ultrasonography
1
1989
411
0.000
Why?
Athletic Injuries
1
1988
51
0.000
Why?
Iris Diseases
1
1987
2
0.000
Why?
Risk-Taking
1
1988
150
0.000
Why?
Temperature
1
1988
290
0.000
Why?
Hydrogen-Ion Concentration
1
1988
405
0.000
Why?
Ultrasonic Therapy
1
1985
5
0.000
Why?
Carbon Tetrachloride
1
1985
8
0.000
Why?
Mice
1
1999
9848
0.000
Why?
Occupational Diseases
1
1988
257
0.000
Why?
Hematoxylin
1
1985
11
0.000
Why?
Eosine Yellowish-(YS)
1
1985
12
0.000
Why?
Neoplasm Transplantation
1
1985
158
0.000
Why?
In Vitro Techniques
1
1986
467
0.000
Why?
Chemical and Drug Induced Liver Injury
1
1985
38
0.000
Why?
Computers
1
1985
48
0.000
Why?
Methods
1
1985
39
0.000
Why?
Rabbits
1
1985
314
0.000
Why?
Combined Modality Therapy
1
1985
323
0.000
Why?
Neoplasm Invasiveness
1
1985
228
0.000
Why?
Preoperative Care
1
1985
150
0.000
Why?
Lacrimal Apparatus Diseases
1
1982
1
0.000
Why?
Dermoid Cyst
1
1982
3
0.000
Why?
Epidermal Cyst
1
1982
8
0.000
Why?
Fibroma
1
1982
12
0.000
Why?
Hemangioma
1
1982
26
0.000
Why?
China
1
1982
101
0.000
Why?
Carcinoma
1
1982
116
0.000
Why?
Seddon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (693)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_